Literature DB >> 17080509

Determination of dopamine and its relativity of baicalin in rat nuclei after intravenous administration of flavonoids from Scutellariae radix.

Long Chen1, Lujun Zhang, Xueli Wang, Han Lin, Lijun Du.   

Abstract

Baicalin is an active component of Scutellariae radix extracts. It can cross the blood-brain barrier and distribute in cerebral nuclei. However, its mechanism and the effects on the nuclei where it accumulates remain unclear. We used an HPLC-electrochemical detection method to determine the dopamine in cerebral nuclei after intravenous administration of flavonoids from Scutellariae radix and analyzed the relativity between baicalin and DA in cerebral nuclei. We found that the dopamine system is another target system of brain function which baicalin acts on. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17080509     DOI: 10.1002/bmc.722

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  [Effect of baicalin on behavioral characteristics of rats with attention deficit hyperactivity disorder].

Authors:  Rong-Yi Zhou; Xin-Min Han; Jiao-Jiao Wang; Hai-Xia Yuan; Ji-Chao Sun; Yue You; Yu-Chen Song
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

2.  Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2/TNFα.

Authors:  Hui-Ying Li; Jun Hu; Shuang Zhao; Zhi-Yi Yuan; Hong-Jiao Wan; Fan Lei; Yi Ding; Dong-Ming Xing; Li-Jun Du
Journal:  J Biomed Biotechnol       Date:  2012-03-21

3.  Baicalin regulates the dopamine system to control the core symptoms of ADHD.

Authors:  Rongyi Zhou; Jiaojiao Wang; Xinmin Han; Bingxiang Ma; Haixia Yuan; Yuchen Song
Journal:  Mol Brain       Date:  2019-02-08       Impact factor: 4.041

4.  Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA.

Authors:  Li Tu; Zhuo-Yu Wu; Xiu-Lin Yang; Qian Zhang; Ran Gu; Qian Wang; Tian Tian; Huan Yao; Xiang Qu; Jin-Yong Tian
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.